Evolent Health, Inc. (EVH) Presents at UBS Global Healthcare Conference 2025 Transcript

Group 1 - The company's stock reacted positively to the third quarter results, which included a significant new business win and an improved outlook [1] - There is a concern regarding visibility into 2026 due to potential membership losses in HICS and Medicaid [1] - The company is facing questions about how to frame the potential loss of numbers in HICS and whether the identity of the customer matters [2] Group 2 - The discussion aims to streamline the financial model in light of the uncertainties surrounding membership losses [2]